Published in News
The GACD call for type 2 diabetes research proposals is now open. So, why are GACD Member Agencies going to fund research on diabetes?
Please see the Diabetes call webpage for the call outline, deadlines, further information and details on how to apply.
In the past twenty years the global death rate from diabetes has doubled (1) and the World Health Organization (WHO) is predicting that this will increase by two thirds by 2030. It is currently estimated that 347 million people worldwide suffer from diabetes, with more than 80% living in low- and middle-income countries. Of those suffering from diabetes, type 2 comprises 90% of this population around the world (2). Halting the rise in prevalence of diabetes has been identified as one of the 9 WHO NCD global voluntary targets to be met by Member States by 2025.
With the burden of this chronic non-communicable disease ever-increasing the Global Alliance for Chronic Diseases (GACD) has agreed to launch a call for proposals on the prevention and treatment of type 2 diabetes, with a focus on implementation and intervention research in low- and middle-income countries, and indigenous populations in Canada and Australia. The emphasis of this initiative is on existing approaches to prevention and control of type 2 diabetes rather than development of new treatments.
In order to maximise the impact of the joint call, research teams applying for funding are expected to consist of researchers from low- and middle-income countries and high-income countries.
If you would like to form a potential partnership with researchers or institutions that are based in our Funding Agencies’ countries, please join our professional forum on LinkedIn to get in touch with other researchers around the world.